chr11-64752454-G-C

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_005609.4(PYGM):ā€‹c.1569C>Gā€‹(p.Leu523Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0159 in 1,614,210 control chromosomes in the GnomAD database, including 237 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.012 ( 12 hom., cov: 32)
Exomes š‘“: 0.016 ( 225 hom. )

Consequence

PYGM
NM_005609.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.277
Variant links:
Genes affected
PYGM (HGNC:9726): (glycogen phosphorylase, muscle associated) This gene encodes a muscle enzyme involved in glycogenolysis. Highly similar enzymes encoded by different genes are found in liver and brain. Mutations in this gene are associated with McArdle disease (myophosphorylase deficiency), a glycogen storage disease of muscle. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 11-64752454-G-C is Benign according to our data. Variant chr11-64752454-G-C is described in ClinVar as [Benign]. Clinvar id is 95293.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64752454-G-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.277 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0117 (1784/152366) while in subpopulation NFE AF= 0.0177 (1202/68034). AF 95% confidence interval is 0.0168. There are 12 homozygotes in gnomad4. There are 812 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PYGMNM_005609.4 linkuse as main transcriptc.1569C>G p.Leu523Leu synonymous_variant 13/20 ENST00000164139.4 NP_005600.1 P11217-1
PYGMNM_001164716.1 linkuse as main transcriptc.1305C>G p.Leu435Leu synonymous_variant 11/18 NP_001158188.1 P11217-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PYGMENST00000164139.4 linkuse as main transcriptc.1569C>G p.Leu523Leu synonymous_variant 13/201 NM_005609.4 ENSP00000164139.3 P11217-1
PYGMENST00000377432.7 linkuse as main transcriptc.1305C>G p.Leu435Leu synonymous_variant 11/182 ENSP00000366650.3 P11217-2

Frequencies

GnomAD3 genomes
AF:
0.0117
AC:
1784
AN:
152248
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00477
Gnomad AMI
AF:
0.0571
Gnomad AMR
AF:
0.0148
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00602
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0177
Gnomad OTH
AF:
0.0120
GnomAD3 exomes
AF:
0.0100
AC:
2518
AN:
251342
Hom.:
23
AF XY:
0.0101
AC XY:
1368
AN XY:
135884
show subpopulations
Gnomad AFR exome
AF:
0.00486
Gnomad AMR exome
AF:
0.00801
Gnomad ASJ exome
AF:
0.00298
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000196
Gnomad FIN exome
AF:
0.00591
Gnomad NFE exome
AF:
0.0170
Gnomad OTH exome
AF:
0.0114
GnomAD4 exome
AF:
0.0163
AC:
23833
AN:
1461844
Hom.:
225
Cov.:
32
AF XY:
0.0158
AC XY:
11488
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.00597
Gnomad4 AMR exome
AF:
0.00841
Gnomad4 ASJ exome
AF:
0.00364
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000243
Gnomad4 FIN exome
AF:
0.00711
Gnomad4 NFE exome
AF:
0.0197
Gnomad4 OTH exome
AF:
0.0147
GnomAD4 genome
AF:
0.0117
AC:
1784
AN:
152366
Hom.:
12
Cov.:
32
AF XY:
0.0109
AC XY:
812
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.00476
Gnomad4 AMR
AF:
0.0148
Gnomad4 ASJ
AF:
0.00461
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00602
Gnomad4 NFE
AF:
0.0177
Gnomad4 OTH
AF:
0.0118
Alfa
AF:
0.0141
Hom.:
4
Bravo
AF:
0.0126
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0148
EpiControl
AF:
0.0164

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disease, type V Benign:4
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 01, 2023- -
not specified Benign:3
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxApr 11, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Oct 09, 2012- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicMay 17, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
5.4
DANN
Benign
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs114138772; hg19: chr11-64519926; API